<font size=2 face="sans-serif"><b>For immediate release: Tuesday 23 October
2012</b></font>
<br>
<br><font size=2 face="sans-serif"><b>BMJ Group launches six specialty
editions of its open access title BMJ Open</b><br>
<br>
The international medical publisher BMJ Group has launched six specialty
editions of its innovative online journal <b><i>BMJ Open </i></b>(</font><a href=http://www.bmjopen.com/editions><font size=2 color=blue face="sans-serif"><u>bmjopen.com/editions</u></font></a><font size=2 face="sans-serif">)
to coincide with Open Access Week<b>.*<i> </i></b></font>
<br>
<br><font size=2 face="sans-serif">The editions<b><i> </i></b>showcase
BMJ Open’s specialist research, and will initially cover dermatology,
HIV/AIDS, infectious diseases, neurology, obstetrics & gynaecology,
and oncology.</font>
<br><font size=2 face="sans-serif"> </font>
<br><font size=2 face="sans-serif"><b><i>BMJ Open,</i></b> which launched
in February 2011, is BMJ Group’s first online general medical journal
dedicated solely to publishing open access research. </font>
<br><font size=2 face="sans-serif"> </font>
<br><font size=2 face="sans-serif">All its research, supplementary files,
and peer reviewers' reports are fully and openly available online. Underlying
data, where available, is linked to in open repositories, such as Dryad.</font>
<br><font size=2 face="sans-serif"><br>
To date, <b><i>BMJ Open</i></b> has published more than 600 original research
papers and protocols, many of which have attracted considerable attention
from academics, healthcare professionals, and the media. </font>
<br><font size=2 face="sans-serif"> </font>
<br><font size=2 face="sans-serif">High impact studies have included a
technique to pick up outbreaks of hospital acquired infections more quickly
from Oxford University; the potential link between sleeping pills and cancer
from California’s Scripps Clinic; and unique research on the wellbeing
and quality of life of people with locked-in syndrome in France. <br>
<br>
Commenting on the launch of the new editions, <b><i>BMJ Open’s</i></b>
Editor in Chief, Dr Trish Groves said: “BMJ Open has grown rapidly in
reputation and content, and we're delighted to be able to increase still
further the visibility of the journal's specialty research in these new
editions.” </font>
<br><font size=2 face="sans-serif"> </font>
<br><font size=2 face="sans-serif">She added: “The title is now a natural
home for open access medical research from all fields." </font>
<br><font size=2 face="sans-serif"><b> </b></font>
<br><font size=2 face="sans-serif"><b>Contact:</b></font>
<br><font size=2 face="sans-serif">Stephanie Burns, BMJ Group Press Office,
London, UK</font>
<br><font size=2 face="sans-serif">Tel: + 44 (0)20 7383 6920</font>
<br><font size=2 face="sans-serif">Email: </font><a href=mailto:sburns@bmjgroup.com><font size=2 color=blue face="sans-serif"><u>sburns@bmjgroup.com</u></font></a>
<br><font size=2 face="sans-serif"><b> </b></font>
<br><font size=2 face="sans-serif"><b>Notes for editors:</b><br>
*Open Access Week (Oct 22-28) is a global event now in its sixth year,
which offers an opportunity for academics and researchers to learn about
the potential benefits of open access, share what they’ve learned with
colleagues, and help make open access common practice in scholarship and
research. </font><font size=2 color=blue face="sans-serif"><u><br>
</u></font><a href=http://www.openaccessweek.org/page/about><font size=2 color=blue face="sans-serif"><u>http://www.openaccessweek.org/page/about</u></font></a>
<br>
<br><font size=2 face="Arial"><b>Stephanie Burns</b></font><font size=3>
</font>
<br><font size=2 face="Arial"><b>BMJ Group PR Executive</b></font><font size=3>
</font>
<br><font size=2 face="Arial"><b> </b></font><font size=3> </font>
<br><font size=2 face="Arial">BMA House</font><font size=3> </font>
<br><font size=2 face="Arial">Tavistock Square</font><font size=3> </font>
<br><font size=2 face="Arial">London</font><font size=3> </font>
<br><font size=2 face="Arial">WC1H 9JR</font><font size=3> </font>
<br><font size=2 face="Arial"> </font><font size=3> </font>
<br><font size=2 face="Arial"><b>Tel: </b>+44 (0)207 383 6920</font><font size=3>
</font>
<br><font size=2 face="Arial"><b>Fax: </b>+44 (0)207 383 6661</font><font size=3>
</font>
<br><font size=2 face="Arial"><b>Web: </b></font><a href=http://group.bmj.com/><font size=2 color=blue face="Arial"><u>http://group.bmj.com</u></font></a><font size=2 color=blue face="Arial">
</font>
<br><font size=2 face="Arial"><b> </b></font><font size=3> </font>
<br><font size=2 color=blue face="Arial"><b><u>Twitter</u></b></font><font size=3 color=blue>
</font><font size=2 face="Arial"><b>| </b></font><font size=2 color=blue face="Arial"><b><u>Facebook</u></b></font><font size=3 color=blue>
</font>
<br><br clear="both">
_______________________________________________________________________<BR>
The BMJ Group is one of the world's most trusted providers of medical information for doctors, researchers, health care workers and patients group.bmj.com. This email and any attachments are confidential. If you have received this email in error, please delete it and kindly notify us. If the email contains personal views then the BMJ Group accepts no responsibility for these statements. The recipient should check this email and attachments for viruses because the BMJ Group accepts no liability for any damage caused by viruses. Emails sent or received by the BMJ Group may be monitored for size, traffic, distribution and content. BMJ Publishing Group Limited trading as BMJ Group. A private limited company, registered in England and Wales under registration number 03102371. Registered office: BMA House, Tavistock Square, London WC1H 9JR, UK.<BR>
_______________________________________________________________________<BR>